David Coman

Mr. David Coman is a Chief Executive Officer at BGB Group LLC and a SVP-Corporate Communications & Patient Recruitment at Quintiles Transnational Corp.
Mr. Coman was previously employed as a Chief Executive Officer by Science 37, Inc., a Chief Executive Officer by Science 37 Holdings, Inc., a Chief Strategy Officer by ERT Operating Co., a Chief Marketing Officer by Dendrite International, Inc., a Chief Marketing Officer by IMS Health, Inc. /Private Group/, a Chief Marketing Officer by IQVIA, Inc., a Chief Executive Officer & Director by Lifesci Acquisition II Corp., and a Principal by Young & Rubicam Brands, Inc. He received his undergraduate degree from Michigan State University and an MBA from Kellogg School of Management.